Association between interleg systolic blood pressure difference and apparent peripheral neuropathy in US adults with diabetes: a cross-sectional study

Table 2 Multiple analysis of ILSBPD and peripheral neuropathy

ILSBPD, mmHg	N	Peripheral neuropathy presence, N (%)	Crude model		Adjusted model I		Adjusted model II
ILSBPD, mmHg	N	Peripheral neuropathy presence, N (%)	OR (95% CI)	P value	OR (95% CI)	p value	OR (95% CI)	P value
Continuous*	1051	243 (23.1)	1.14 (1.07, 1.21)	< 0.001	1.11 (1.04, 1.19)	0.002	1.07 (0.98, 1.16)	0.160
Group 1
< 5	411	80 (19.5)	Ref.		Ref.		Ref.
≥ 5	640	163 (25.5)	1.41 (1.05, 1.91)	0.025	1.23 (0.90, 1.68)	0.192	1.08 (0.71, 1.63)	0.733
Group 2
< 10	715	143 (20.0)	Ref.		Ref.		Ref.
≥ 10	336	100 (29.8)	1.69 (1.26, 2.28)	0.001	1.51 (1.11, 2.06)	0.008	1.43 (0.94, 2.16)	0.094
Group 3
< 15	852	171 (20.1)	Ref.		Ref.		Ref.
≥ 15	199	72 (36.2)	2.26 (1.62, 3.15)	< 0.001	2.07 (1.47, 2.93)	< 0.001	1.79 (1.11, 2.91)	0.018

Model I Adjusted for age, gender and race
Model II Adjusted for age, gender, race, brachial SBP, HbA1c, TCHO, HDL-c, hypertension history, hypercholesterolemia history, peripheral artery disease status and duration of diabetes
ILSBPD interleg systolic blood pressure difference, SBP systolic blood pressure, HbA1c glycosylated hemoglobin, TCHO total cholesterol, HDL-c high-density lipoprotein-cholesterol
*Every 5-mmHg increment of ILSBPD

ISSN: 2072-1315